Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study
Mansoor Zafar, Mangala Karkhanis, Muhammad Shahbaz, Alisha Khanna, Lucinda Barry, Saba Alam, Kamal Lawrence, Bipin Pun, Reem Eldebri, Opeyemi Makanjuola, Dana Safarova, Mariya Farooq, Hesam Nooredinavand, Frderic Cuison, Karuna Subba, Ratan Singh Randhawa, Johannes Hegner, Ojofeitimi Oluwamayowa, Amr Elyasaky, Bolurin Adekunle, Manivannan Periasamy, Mohamed Abdelbagi, Zahra Maryam, Bao Khuu, Andreia Esteves Morete, Giulio Ciroi, Steve Moran, William O'neill, Maaryah J Zafar, Nadiyah Zafar, Mirej Patel, Raphael Golez, Abubakr Hadid, Tila Muhammad, Philip Mayhead, Mark Whitehead, Umesh Dashora
Postgraduate Medical Journal, doi:10.1136/postgradmedj-2021-140564
Background The role of vitamin D in increased mortality with SARS-COV-2 virus, namely, COVID-19, remains uncertain. We analysed all the patients who were treated as COVID-19-positive with or without a positive swab and were tested for vitamin D levels. Methods This was a retrospective, study involving 1226 patients swabbed for SARS-CoV-2 between the 10 February 2020 and 1 May 2020 at two hospitals of East Sussex Healthcare NHS Trust. Patients who were swabpositive for COVID-19 or treated as COVID-19-positive on clinical grounds even though swab results were negative were included in this study. We analysed the association of vitamin D levels and mortality, assessing linear and non-linear associations. Results A total of 1226 patients had SARS-CoV-2 RNA swabs in this period with age range from 1 year to 101 years. A cohort of 433 of these patients had swabs and recent vitamin D levels anytime in the previous 3 months. Mortality rates were not found to be associated with vitamin D levels (OR=1.04, 95% CI 0.96 to 1.12). Conclusion Our findings suggest similar mortality risk from COVID-19 irrespective of the levels of vitamin D. Larger prospective studies will be needed to confirm these findings.
Collaborators Information is entered in the paper as coauthors in the main paper as previously advised by the journal. Contributors MZ designed the study and formed the steering group, which was responsible for ongoing evaluation for study design development, and led the methodological data collection from hospital electronic system towards comorbidities and access to blood test results. SM and WO assisted with electronic record for COVID-19 swab results for all patients from Conquest Hospital and Eastbourne District General Hospital. MZ, MK, MS, AK, LB, SA, KL, BP, RE, OM, DS, MF, HN, FC, KS, RSR, JH, OO, AE, BA, MP, MA, ZM, BK, AEM, GC, MJZ, NZ, MP, RG, AH and TM contributed with data acquisition and data entry. MZ, MK, MS, RSR, RE, SA and BP were responsible for the ongoing evaluation for study design development. SA, JH, DS, BP, ZM, BK, MK, JH and MP assisted with data assimilation, assisted by all other contributors. MJZ and NZ proofread the entire data for any errors. MZ and SA verified the data. MZ acted as guarantor. Statistical analysis was led by MZ, with intellectual review and support by Ms Jackie Cooper. MZ wrote the manuscript, which was reviewed by UD, MW and PM. All authors and UD approved the final version of the manuscript. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared. Patient consent for publication Not required...
References
Bosworth, Levin, Robinson-Cohen, The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease, Kidney Int,
doi:10.1038/ki.2012.193Bucak, Ozturk, Almis, Is there a relationship between low vitamin D and rotaviral diarrhea?, Pediatr Int,
doi:10.1111/ped.12809Carpagnano, Lecce, Quaranta, Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest,
doi:10.1007/s40618-020-01370-xCui, Xu, Li, Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system, Redox Biol,
doi:10.1016/j.redox.2019.101295D'avolio, Avataneo, Manca, 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients,
doi:10.3390/nu12051359Diagnostics, Elecsys® vitamin D total II
Draak, De Greef, Faber, The minimum clinically important difference: which direction to take, Eur J Neurol,
doi:10.1111/ene.13941Fasano, Cereda, Barichella, COVID-19 in Parkinson's disease patients living in Lombardy, Italy, Mov Disord,
doi:10.1002/mds.28176Grädel, Merker, Mueller, Schuetz, Screening and treatment of vitamin D deficiency on hospital admission: is there a benefit for medical inpatients?, Am J Med,
doi:10.1016/j.amjmed.2015.06.034Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res,
doi:10.1007/s40520-020-01570-8Isaia, Giorgino, Rini, Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors, Osteoporos Int,
doi:10.1007/s00198-003-1390-7Laird, Rhodes, Kenny, Vitamin D and inflammation: potential implications for severity of Covid-19, Ir Med J
Maclaughlin, Holick, Aging decreases the capacity of human skin to produce vitamin D3, J Clin Invest,
doi:10.1172/JCI112134Pinzon, Pradana, Vitamin D deficiency among patients with COVID-19: case series and recent literature review, Trop Med Health,
doi:10.1186/s41182-020-00277-wTorjesen, Covid-19: public health agencies review whether vitamin D supplements could reduce risk, BMJ,
doi:10.1136/bmj.m2475Webmd, Vitamin, overview, uses, side effects, precautions, interactions, dosing and reviews
Woloshin, Patel, Kesselheim, False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications, N Engl J Med,
doi:10.1056/NEJMp2015897Zafar, Ewnetu, Ahmed, COVID-19 vaccination-induced rash: does the choice of vaccine matter?, Cureus,
doi:10.7759/cureus.15490Zafar, Randhawa, Hegner, Can HbA1c levels be used as an independent marker of mortality and morbidity risk in patients with COVID19 positive swabs? -a retrospective observational study, University of Toronto Medical Journal
Zafar, Shahbaz, Karkhanis, A retrospective observational study: is absolute lymphocyte count a prognostic marker in COVID-19?, Cureus,
doi:10.7759/cureus.16554
